ResMed Other Long Term Liabilities (Quarterly) Analysis

ResMed, Inc. (RMD)

254.67 -3.17 (-1.23%) USD | NYSE | Jan 13, 16:00

254.74 +0.07 (+0.03%) Pre-Market: 20:00

View Other Long Term Liabilities (Quarterly) for RMD.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

Boston Scientific Corp.	Upgrade
Abbott Laboratories	Upgrade
Stryker Corp.	Upgrade
West Pharmaceutical Services, Inc.	Upgrade
Insulet Corp.	Upgrade